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Abstract
Background
Antimicrobial resistance remains a growing and significant concern in human and veterinary
medicine. Current laboratory methods for the detection and surveillance of antimicrobial
resistant bacteria are limited in their effectiveness and scope. With the rapidly developing
field of whole genome sequencing beginning to be utilised in clinical practice, the ability to
interrogate sequencing data quickly and easily for the presence of antimicrobial resistance
genes will become increasingly important and useful for informing clinical decisions. Addi-
tionally, use of such tools will provide insight into the dynamics of antimicrobial resistance
genes in metagenomic samples such as those used in environmental monitoring.
Results
Here we present the Search Engine for Antimicrobial Resistance (SEAR), a pipeline and
web interface for detection of horizontally acquired antimicrobial resistance genes in raw
sequencing data. The pipeline provides gene information, abundance estimation and the
reconstructed sequence of antimicrobial resistance genes; it also provides web links to
additional information on each gene. The pipeline utilises clustering and read mapping to
annotate full-length genes relative to a user-defined database. It also uses local alignment
of annotated genes to a range of online databases to provide additional information. We
demonstrate SEAR’s application in the detection and abundance estimation of antimicrobial
resistance genes in two novel environmental metagenomes, 32 human faecal microbiome
datasets and 126 clinical isolates of Shigella sonnei.
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Conclusions
We have developed a pipeline that contributes to the improved capacity for antimicrobial
resistance detection afforded by next generation sequencing technologies, allowing for
rapid detection of antimicrobial resistance genes directly from sequencing data. SEAR uses
raw sequencing data via an intuitive interface so can be run rapidly without requiring
advanced bioinformatic skills or resources. Finally, we show that SEAR is effective in
detecting antimicrobial resistance genes in metagenomic and isolate sequencing data from
both environmental metagenomes and sequencing data from clinical isolates.
Introduction
The global threat of antimicrobial resistance is growing at an alarming rate; infections that
were once easily treatable now constitute public health crises [1]. This has lead to the consensus
that more must be done to monitor and combat the occurrence and spread of antimicrobial
resistance [2, 3]. Current diagnostic laboratory practice for the detection of antimicrobial resis-
tance relies on isolate culturing, followed by growth inhibition assays for the identification of
resistant phenotypes and determination of Minimum Inhibitory Concentrations against a
range of antimicrobials (MICs) [4]. Alternatively, antimicrobial resistance genes (ARGs) can
be identified using polymerase chain reaction (PCR) and quantified using real-time PCR,
requiring specific primers for the amplification of target sequences [5]. These approaches take
time, consume resources, and have limitations that may result in clinically relevant resistances
being undetected e.g. phenotypic testing will miss non-culturable bacteria and non-expressed
ARGs, whereas limitations of multiplex composition and size in molecular testing complicates
the detection of ARGs [6, 7].
Perhaps not surprisingly, the Centers for Disease Control and Prevention (CDC) identified
one of the current downfalls in the approach to combatting antimicrobial resistance as the
poor use of advanced molecular detection (AMD) technologies [8]. AMD technologies, such as
the whole genome sequencing of bacterial isolates as well as uncultured bacteria (metagenomic
sequencing), have the potential to identify antimicrobial resistance more quickly and effectively
than conventional laboratory assays [8]. In addition to these well-understood advantages,
AMD technologies can also be applied to circumvent the requirement of prior knowledge of
causative agents and provide clinically relevant information for the treatment and surveillance
of pathogens as well as antimicrobial resistance [9]. Upon receipt of a metagenomic (e.g. envi-
ronmental or faecal microbiome) or isolate sample, DNA can be extracted, compiled into a
library and sequenced within hours [10]. Indeed, AMD approaches to pathogen detection are
currently being developed and seek to identify pathogens directly from metagenomic samples
within clinically relevant timeframes [11]. Recent studies have also shown AMD to be effective
in the epidemiological tracking of pathogens, as well as the detection of ARGs present in their
genomes [12, 13]. AMD offers an alternative screening tool that may be quicker than tradi-
tional culture-based techniques. For example, the detection ofMycobacterium tuberculosis
requires inoculated isolation media to be incubated for several days in order to diagnose infec-
tion and additional time for phenotypic characterisation of antimicrobial resistance [14]. This
highlights the potential for developing more efficient diagnostic tests and the utilisation of
AMD technologies to create more rapid alternatives for ARG detection.
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In addition to these direct clinical applications, AMD technologies are also beginning to
become a common tool in the detection of ARGs in the environment, which is vital for identify-
ing reservoirs of ARGs [15–17]. However, there is need to establish a metagenomic framework
for use in the monitoring of ARGs within the environment in order to influence public health
decisions and the growing concern over antimicrobial resistance [18]. This must include the
development of reliable surveillance methods and tools for risk assessment [19]. When design-
ing metagenomic tools for the environmental monitoring of ARGs, it is therefore necessary to
provide context in terms of the relative abundance of ARGs, so that these can be correlated with
environmental variables (e.g. such as antimicrobial concentrations, etc.) as well as to obtain
information on the mobile genetic elements (MGE) and pathogens that they are associated with.
Currently published resources available for ARG detection are online databases that use the
Basic Local Alignment Search Tool (BLAST) algorithm to find possible matches between the
database and query sequences (e.g. ARDB, CARD, ResFinder) [20–23]. To our knowledge, no
existing tools give an ARG abundance measure or simultaneously provide MGE information.
The targeting of full-length gene matches using BLAST requires a sequence assembly step, add-
ing time, infrastructure requirements, and complexity to the analysis. Furthermore, full-length
gene assembly is often difficult to achieve in metagenomic samples where coverage is fre-
quently low and uneven across the sample. Ideally, raw sequencing data would be used directly
to rapidly identify and quantify ARGs of interest. Although mapping-based approaches have
been used for individual studies [24, 25] and tools that work directly with reads (though on
non-ARG databases) such as the SEED subsystems and SRST2 can be applied to work to this
aim [26], there is as yet no such ARG-detection algorithm. Here, we present an automated
pipeline, the Search Engine for Antimicrobial Resistance (SEAR), which quickly and accurately
identifies antimicrobial resistance information from biological samples. Furthermore, it also
provides abundance estimates and returns the true sample full-length reconstructed gene
sequence. To demonstrate efficacy, we present the application of the pipeline to a range of
sequencing data types including novel environmental metagenomes, human faecal metagen-
omes and clinical isolates of pathogenic enteric bacteria (Shigella sonnei).
Materials and Methods
SEAR requirements
Reference databases. SEAR requires reference databases for read subtraction and read
clustering. Details of the supplied databases and how the user can supply their own custom
databases are given in supplemental methods (Supplemental methods A in S1 File). The default
databases supplied for read subtraction and read clustering are the human genome (HG19
build) and the ARG-annot database [27].
Hardware. Minimum hardware requirements for SEAR comprise a Unix server (tested
using Ubuntu 10.04) with ~2 GB of disk space for reference data and software dependencies
(see S1 Table). Whilst running, SEAR requires up to 2X the input FASTQ file size (bytes) in
both RAM and disk space for temporary file storage.
SEAR
The pipeline. SEAR is a pipeline consisting of Perl, Shell and R scripts that call on several
pieces of open source software and utilise a customisable reference database to annotate ARGs
direct from short-read sequencing data. SEAR is downloadable from http://computing.bio.
cam.ac.uk/sear/SEAR_WEB_PAGE/SEAR.html, in stand-alone command-line and web-based
versions (Fig 1).
Search Engine for Antimicrobial Resistance
PLOS ONE | DOI:10.1371/journal.pone.0133492 July 21, 2015 3 / 12
Fig 1. Screen shot of SEARwebinterface including homepage (A) and quick start settings (B).
doi:10.1371/journal.pone.0133492.g001
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The pipeline follows five main steps in the annotation of ARGs: (1) processing of input files,
(2) clustering of sequence reads to known ARGs in user-defined (or pre-loaded) database, (3)
mapping of reads to reference sequences, (4) ARG annotation and calculation of relative abun-
dance and (5) local alignment of annotated ARGs to online databases.
(1) Processing of input files
The pipeline accepts raw or compressed (.gz) FASTQ files (either 33 or 64 ASCII encoding)
from metagenomic, metatranscriptomic or isolate sequencing. Where more than one input file
(e.g. paired-end data) is provided, these files are merged to give a single input file (pair-end
information is not currently utilised in the pipeline). The pipeline has the optional step of pre-
filtering reads, by removing those that map against a user-defined reference, such as the
human genome or a bacterial strain. FASTQ files are quality checked using user-defined cut
offs and converted to FASTA formatted reads.
(2) Clustering of sequence reads to ARG database
The pipeline is supplied with a custom ARG database that has been built by clustering and
annotating the ARGs held in the ARGannot-database [27]. Notably however, other ARG data-
bases can be used or the user can use a custom FASTA file (Supplemental methods B in S1
File). Reads are clustered to the ARG database by global alignment with USEARCH (version
7.0.959) using a default identity cut-off of 99% [28]. Where multiple matches occur, the read is
clustered with the highest identity match. SEAR parses the clusters by grouping reads to each
matched reference gene and retrieving corresponding FASTQ information for each matched
read.
(3) Mapping of clustered sequence reads to ARG references
The Burrows-Wheeler Aligner (BWA-mem version 0.7.8) [29] is used for read mapping each
cluster of FASTQ reads to the corresponding reference gene. Samtools is then used to analyse
the BWA alignment and generate a consensus sequence using mpileup [30].
(4) ARG annotation and relative abundance
The consensus sequences are used to annotate ARGs and calculate relative abundance values;
an ARG is present in the sample if sequence reads can be mapped to the ARG reference
sequence above the defined coverage cut-off (coverage is the percentage length of reference
ARG with mapped reads). For relative abundance calculation, SEAR uses a similar method to
the reads per kilobase/million reads (RPKM) method that is commonly used in transcriptome
studies [31]. Full details on cut-off values and abundance calculation are given in supplemental
methods (Supplemental methods C in S1 File).
(5) Local alignment
The consensus sequences for annotated ARGs are aligned to the NCBI nucleotide and protein
databases using commandline BLAST [23] (using the–remote BLAST service by default, see
documentation to utilise local database versions). In addition, sequences are also aligned to the
current Repository of Antimicrobial Resistance Cassettes (RAC) [32] and Antibiotic Resistance
Database (ARDB) [20] databases using BLAST (though ARDB has not recently been curated).
Pipeline outputs. In both command-line and web versions of SEAR, output includes:
graphical overview, ARG annotations, relative abundance scores, consensus sequences, flat
files (html, csv, blast files) and links to further gene information and homologues found in
Search Engine for Antimicrobial Resistance
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online databases (such as the repository of antimicrobial resistance cassettes, NCBI non-redun-
dant nucleotide and protein databases).
Demonstrating SEAR utility
Data sets used in this study. Several datasets were used to demonstrate the utility of this
pipeline across broad data categories. All datasets were analysed using a UNIX server (Ubuntu
10.04) running SEAR with default parameters (99% clustering identity and 90% coverage cut-
off for ARG annotation, full default parameter list found in S2 Table).
Novel environmental metagenomes. Information on metagenome sample collection,
library construction and sequencing are provided in supplemental methods (Supplemental
methods D, E F in S1 File). Briefly, faecal wastewater effluent samples were taken from a dairy
farm (latitude: 52.22259, longitude: 0.02603) and a metropolitan (human) wastewater treat-
ment works (WWTW) (latitude: 52.234469, longitude: 0.154614). Samples were vacuum fil-
tered through 0.22μmmembranes, DNA extracted and sequenced using the Illumina HiSeq
2000 platform.
Pre-existing metagenomic and clinical isolate data. Human Microbiome Project (HMP)
data for 32 Spanish human faecal microbiomes (for which the ARGs have previously been
characterised in an in silico study by Forslund et al. [25]) were used (SRA Study ERP002061).
Additionally, SEAR was used to detect ARGs in a global dataset of 126 clinical isolates of the
pathogenic bacteria Shigella sonnei (SRA Study ERP000182) [33]. In the case of the clinical iso-
lates, SEAR ARG detection was compared with the published ARG content of the isolates, with
SEAR being run with default parameters on a custom reference database of ARGs originally
detected by 100% mapping [33]. Further details on datasets are provided in S3 Table.
Results
To test the utility of SEAR we ran the pipeline using a variety of sample types (environmental
metagenomes, human faecal microbiome and bacterial clinical isolate), recorded pipeline run
times (S4 Table) and then investigated the presence and abundance of ARGs in all samples.
Discrimination of ARG presence and abundance between
environmental metagenomes
A total of 28 (15 in each) ARGs were identified among the environmental metagenomes from
WWTW effluent and farm waste effluent (Fig 2). Only two genes, strA and strB (both confer-
ring aminoglycoside resistance), were common between the metagenomes and each gene
found in both sets was five times more abundant in the WWTW effluent compared to the farm
effluent when using the normalised abundance values for the combined datasets. The WWTW
effluent had ARGs conferring resistance to a total of four antimicrobial resistance profiles with
the most diverse (i.e. greatest number of ARGs) being the aminoglycoside resistance profile
and the greatest abundance being ARGs conferring tetracycline resistance. In contrast, the
farm effluent had ARGs conferring resistance to five resistance profiles with the most diverse
being the beta lactam resistance profile and the most abundant also being tetracycline resis-
tance (Fig 2). The most abundant ARGs in the metagenome datasets were tetracycline resis-
tance genes; tetC (41.6%) in the farm effluent, and tet39 (15.3%) in the WWTW effluent. A
subset of ARGs identified by SEAR (tetA, qnrB and bla-ACT; chosen to encompass clinically
relevant resistances, drugs with both a long and short history of resistance and chemically
diverse antimicrobials) was confirmed in the original farm effluent DNA sample using PCR.
Briefly, primers were designed using Primer3 [34] and were amplified using GoTaq DNA poly-
merase (Promgega) (not shown).
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Fig 2. SEAR results for environmental metagenomes. The column chart in A shows the breakdown of the number of ARGs in each effluent, grouped by
antimicrobial resistance profile. The column chart in B shows the relative abundance of ARGs found in each metagenome (coloured according to the key).
doi:10.1371/journal.pone.0133492.g002
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Efficacy of SEAR for detecting ARGs in human faecal microbiomes
To assess the efficacy of SEAR for detecting ARGs in microbiome data, SEAR was tested on 32
faecal microbiome samples (S5 Table). ARGs were detected in 31 of the samples and a total of
295 genes conferring resistance to 6 classes of antimicrobials were identified across the samples
(Table 1). Genes conferring resistance to tetracyclines were again the most common ARGs
identified (39% of total ARGs detected).
Accuracy of SEAR ARG detection using clinical isolate sequencing data
To evaluate SEAR’s efficacy in detecting ARGs in clinical isolate sequencing data, SEAR was
run on sequencing data from 126 isolates of the enteric pathogen Shigella sonnei. To evaluate
SEAR’s performance, the results were compared to the ARG detection data presented in the
original publication [33]. Of the 231 detection events (see methods for criteria) originally pre-
sented in the publication, SEAR identified 221 of these, and a further 20 ARGs (Table 2, full
results shown in S6 Table).
Discussion
SEAR is an ARG annotation tool that is freely available and may be downloaded as a cloud
compatible web interface or a stand-alone command line program. It offers advantages over
currently available ARG annotation tools as it provides ARG annotations, relative abundance
Table 1. SEAR detection of ARGs across antimicrobial profile/classes in human faecal microbiomes.
Antimicrobial resistance proﬁle Number of ARGs
Aminoglycosides 54
Beta lactams 38
Quinolones 0
Glycopeptides 0
Macrolides/Lincosamides/Streptogramins 82
Phenicols 1
Rifampicin 0
Sulfonamides 5
Tetracyclines 115
Trimethoprims 0
The table shows the number of genes identiﬁed in each antimicrobial resistance proﬁle for the combined
dataset of HMP samples.
doi:10.1371/journal.pone.0133492.t001
Table 2. Accuracy of SEAR ARG detection using clinical isolate sequencing data.
Reported in Holt et al. [33]
detected not-detected TOTAL
SEAR results detected 221 20 241
not-detected 10 0 10
TOTAL 231 20
The contingency table compares the detection and non-detection of ARGs by SEAR relative to the published ARG detection data for 126 S. sonnei
isolates.
doi:10.1371/journal.pone.0133492.t002
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values, gene sequence and gene information from raw sequencing data without requiring any
sequence assembly. In contrast to tools based on BLAST comparison of de novo assemblies, the
clustering and mapping approach used by SEAR, combined with the customisable database
and annotation parameters, allows the user to detect putative ARGs in incomplete or low cov-
erage sequencing data that is common in metagenomic analyses. SEAR successfully identified
ARGs in sequencing datasets that were generated from novel environmental metagenomic
samples, human microbiomes and clinical isolates of Shigella sonnei.
SEAR was able to detect the ARGs present in two novel environmental metagenomes allow-
ing direct comparison between two different wastewater effluent samples. SEAR identified
meaningful differences among ARGs of clinical interest, for example the presence of quinolone
resistance genes (qnrB and qnrS) exclusively in the wastewater effluent from the farm source. It
also showed that while the two sources had different qualitative ARG characteristics (with
either aminoglycosides or beta-lactams being the most diverse resistance profiles) and in both
tetracycline resistance genes were present in the greatest abundance. In addition to detecting
important differences among these sample types, the confirmation of a subset of identified
ARGs by PCR demonstrated the robustness of the pipeline.
Similarly, SEAR was effective for identifying ARGs from clinical samples. ARGs were
detected in human microbiomes demonstrating the potential of using metagenomic analyses
for the surveillance and management antimicrobial resistance. Additionally, SEAR successfully
identified ARGs in a global dataset of 126 clinical isolates of an important enteric pathogen.
There were a few discrepancies, which were consistent with a given isolate or gene family, how-
ever the results were overwhelmingly consistent. Furthermore, the congruence of ARG detec-
tion results from SEAR with the published ARG content of the isolates further highlighted the
effectiveness of the pipeline, providing further compelling argument for the application of
high-throughput AMD into clinical microbiology.
Limitations and future improvements
SEAR offers increased functionality over existing bioinformatic tools by providing a consensus
sequence of annotated ARGs, links to online resources containing information on the ARGs
(and gene homologs) and a relative abundance estimate for each ARG detected. Each ARG
consensus sequence is generated using reads that clustered to a reference sequence and conse-
quently any variability in the consensus sequence in a metagenomic sample may be due to
either sequencing noise or the presence of multiple bona fide sequence variants. The relative
abundance estimate is relative within an individual sample, however the SEAR output features
the information required to calculate relative abundance across multiple samples. Due to possi-
ble large variations in user file size and upload speed, the SEAR interface and command line
tool are available for use as downloadable packages.
SEAR is designed for detecting ARGs that are horizontally acquired, not antimicrobial resis-
tance that is caused (or inactivated) by single nucleotide polymorphisms (SNPs) e.g. SNPs in
the gyrA gyrase gene that result in quinolone resistance. SNPs are not currently tested for due
to the annotation parameters being calibrated for detecting partial ARG matches to compen-
sate for low sequencing coverage. Hence, such SNPs may be missed by SEAR due to the num-
ber of mismatches permitted or by a low coverage cut-off (though these are both customisable
settings). For these reasons, it is not recommended to include SNP-based resistances in refer-
ence databases used with SEAR as they may lead to false positives. The detection of SNP-based
resistances in metagenomic samples represents a significant future challenge that needs to be
addressed. It should also be stressed that the default SEAR parameters, which are based on
high-stringency read clustering and mapping, result in an analysis that finds ARGs that are
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known in the reference data and it is not suited for discovery of emergent ARGs. The high-
stringency settings are designed to exclude the possibility of non-competitive read mapping
causing false positive results by ensuring that annotated ARGs have a high sequence identity
compared to the reference database.
Conclusion
We have presented a bioinformatic pipeline that is highly effective for detecting ARGs directly
from raw sequencing reads that also provides relative abundance estimation and sequences of
identified genes. We have shown its application on sequence data from metagenomic datasets
and bacterial isolates. We have demonstrated the application of SEAR in potential clinical and
environmental monitoring applications, highlighting the advantages of automated interpreta-
tion of sequencing data for generating timely and informative reports for informing public
health and potentially clinical decision-making. With the increasing drive to integrate AMD
technology and existing laboratory assays in order to combat antimicrobial resistance, we pres-
ent this pipeline as a valuable step towards this important goal.
Availability and requirements
Project name: Search Engine for Antimicrobial Resistance (SEAR)
Project home page:
http://computing.bio.cam.ac.uk/sear/SEAR_WEB_PAGE/SEAR.html
Operating system(s): UNIX
Programming language: Perl
Other requirements: Usearch (v.7), BWA, samtools, R
License: GNU GPL (version 3)
Any restrictions to use by non-academics: na
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